Sakai, Masaki
Yamamoto, Keiko
Mizumura, Hiroaki
Matsumoto, Tomoki
Tanaka, Yasuko
Noda, Yumi
Ishibashi, Kenichi
Yamamoto, Tadashi
Sasaki, Sei
Funding for this research was provided by:
Japan Society for the Promotion of the Science (KAKENHI 15K09301, 15K09302)
Article History
Received: 1 March 2020
Accepted: 1 May 2020
First Online: 11 June 2020
Compliance with ethical standards
:
: The authors have declared that no conflict of interest exists.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institution Ethical Committee of Meiji Pharmaceutical University (approved number: 2609) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Also, the CDI patient gave written informed consent and the protocol was approved by the Institutional Ethical Committee of Nitobe Memorial Nakano General Hospital (approved number 16-045). All procedures performed in animals were approved by the Meiji Pharmaceutical University Committee for Ethics of Experimentation and Animal Care (approved number 2005).
: Informed consent was obtained from all individual participants included in the study.